Artal Group as of Dec. 31, 2015
Portfolio Holdings for Artal Group
Artal Group holds 64 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 40.4 | $2.2B | 115M | 18.71 | |
| Lexicon Pharmaceuticals (LXRX) | 14.4 | $766M | 58M | 13.31 | |
| Weight Watchers International | 12.6 | $671M | 29M | 22.80 | |
| Goldman Sachs (GS) | 2.5 | $135M | 750k | 180.23 | |
| Celgene Corporation | 2.0 | $108M | 900k | 119.76 | |
| Biogen Idec (BIIB) | 2.0 | $107M | 350k | 306.35 | |
| Wal-Mart Stores (WMT) | 1.9 | $102M | 1.7M | 61.30 | |
| Bank Of America Corp | 1.6 | $84M | 5.0M | 16.83 | |
| MetLife (MET) | 1.4 | $72M | 1.5M | 48.21 | |
| JPMorgan Chase & Co. (JPM) | 1.3 | $69M | 1.1M | 66.03 | |
| Incyte Corporation (INCY) | 1.3 | $67M | 620k | 108.45 | |
| Apple Inc equity | 1.2 | $63M | 600k | 105.26 | |
| Spdr S&p 500 Etf (SPY) | 1.0 | $51M | 250k | 203.87 | |
| Alibaba Group Holding (BABA) | 0.9 | $49M | 600k | 81.27 | |
| General Motors Company (GM) | 0.9 | $48M | 1.4M | 34.01 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $45M | 475k | 94.14 | |
| Morgan Stanley (MS) | 0.8 | $41M | 1.3M | 31.81 | |
| Yum! Brands (YUM) | 0.8 | $40M | 550k | 73.05 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $39M | 375k | 104.76 | |
| Bristol Myers Squibb (BMY) | 0.7 | $34M | 500k | 68.79 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $34M | 100k | 338.33 | |
| Qualcomm (QCOM) | 0.6 | $33M | 665k | 49.99 | |
| Kite Pharma | 0.6 | $31M | 500k | 61.62 | |
| Gilead Sciences (GILD) | 0.6 | $30M | 300k | 101.19 | |
| MasterCard Incorporated (MA) | 0.6 | $29M | 300k | 97.36 | |
| Teva Pharmaceutical Industries (TEVA) | 0.6 | $30M | 450k | 65.64 | |
| Ionis Pharmaceuticals (IONS) | 0.5 | $28M | 450k | 61.93 | |
| Nektar Therapeutics (NKTR) | 0.5 | $27M | 1.6M | 16.85 | |
| Merck & Co (MRK) | 0.5 | $26M | 500k | 52.82 | |
| Bluebird Bio (BLUE) | 0.5 | $26M | 410k | 64.22 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $24M | 375k | 64.92 | |
| Linkedin Corp | 0.4 | $23M | 100k | 225.08 | |
| Endo International (ENDPQ) | 0.3 | $18M | 300k | 61.22 | |
| Array BioPharma | 0.3 | $17M | 4.0M | 4.22 | |
| General Electric Company | 0.3 | $16M | 500k | 31.15 | |
| Lendingclub | 0.3 | $16M | 1.4M | 11.05 | |
| Mobileye | 0.3 | $15M | 350k | 42.28 | |
| Micron Technology (MU) | 0.3 | $14M | 1.0M | 14.16 | |
| American Express | 0.3 | $14M | 200k | 69.55 | |
| Visa (V) | 0.2 | $14M | 175k | 77.55 | |
| Citigroup (C) | 0.2 | $13M | 250k | 51.75 | |
| SPDR S&P Biotech (XBI) | 0.2 | $11M | 150k | 70.20 | |
| Time Warner | 0.2 | $9.7M | 150k | 64.67 | |
| Delphi Automotive | 0.2 | $8.6M | 100k | 85.73 | |
| Juno Therapeutics | 0.2 | $8.4M | 190k | 43.97 | |
| Chemocentryx | 0.1 | $7.3M | 900k | 8.10 | |
| Ignyta | 0.1 | $6.4M | 475k | 13.40 | |
| Cellectis S A (CLLS) | 0.1 | $6.5M | 210k | 31.03 | |
| Seres Therapeutics (MCRB) | 0.1 | $6.1M | 175k | 35.09 | |
| Celldex Therapeutics | 0.1 | $5.9M | 375k | 15.68 | |
| Delta Air Lines (DAL) | 0.1 | $5.1M | 100k | 50.69 | |
| BioTime | 0.1 | $5.3M | 1.3M | 4.10 | |
| Jumei Intl Hldg Ltd Sponsored | 0.1 | $4.5M | 500k | 9.06 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $3.9M | 100k | 38.58 | |
| Nantkwest | 0.1 | $3.9M | 225k | 17.33 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.5M | 217k | 11.59 | |
| Agenus (AGEN) | 0.1 | $2.5M | 550k | 4.54 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $2.7M | 160k | 16.60 | |
| Parnell Pharmaceuticals Holdin (PARNF) | 0.0 | $1.9M | 500k | 3.88 | |
| Dimension Therapeutics | 0.0 | $2.0M | 175k | 11.28 | |
| Spectranetics Corporation | 0.0 | $1.5M | 100k | 15.06 | |
| XOMA CORP Common equity shares | 0.0 | $532k | 400k | 1.33 | |
| Ceres | 0.0 | $338k | 1.0M | 0.33 | |
| Colucid Pharmaceuticals | 0.0 | $47k | 5.6k | 8.43 |
